Recent Activities - 2016
August 2016: NRL attends Mapping Workshops in Myanmar
Sue Best, Geraldine Kong and Claire Ryan from NRL, as well as Dr Khin Zaw Latt from FIND (the Foundation of Innovative New Diagnostics), attended two high-level meetings in Nay-Pyi-Taw, Myanmar, in the week of 15 August 2016. The meetings were aimed at facilitating sustainable, long-term outcomes for the project activities under NRL’s sub-contract with FIND, to strengthen the HIV testing and quality management system in Myanmar.
The first meeting was a Mapping Workshop on Documentation for the HIV Viral Load Cascade in Myanmar. The objective of the HIV Viral Load Mapping Workshop was to reach consensus on all the documentation required for HIV viral load testing, in preparation for a scale-up of HIV viral load testing in Myanmar. The aim of the meeting was to identify the documentation needed, define approval mechanisms as well as roles and responsibilities around approval processes, training, monitoring and evaluation, and data management.
Following this meeting, a Mapping Workshop on the Operational Characteristics of HIV Testing Services in Myanmar was conducted. The aim of the Workshop was to bring together key stakeholders involved in HIV testing in Myanmar, to discuss, map and coordinate the systems, documentation and responsibilities for HIV diagnostic testing at decentralised HIV testing sites in Myanmar.
Both Mapping Workshops were well attended by key stakeholders from the National AIDS Program (Department of Public Health), the National Health Laboratory (Department of Medical Services), international non-governmental organisations and key technical partners. Several key outcomes were agreed upon at both Workshops, and are being followed up.
NRL would like to thank FIND, CDC Myanmar and ICAP at Columbia University for their invaluable contributions to the organisation of the Workshops. NRL would also like to thank all attendees for their active participation and for contributing to lively discussions at both Workshops. This work was undertaken with financial support from the United States Centers for Disease Control and Prevention (CDC) under Cooperative Agreement Number 3U2GPS002746.